Cancer Research Consortium of West Michigan (CRCWM)

西密歇根癌症研究联盟 (CRCWM)

• 批准号: 9330824
• 负责人: KATHLEEN J YOST
• 金额: $ 234.11万
• 依托单位: SPECTRUM HEALTH HOSPITALS
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-01 至 2019-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9330824
• 关键词: Address; Adoption; Advisory Committees; Basic Science; Cancer Center; Cancer Patient; Caring; Clinical; Clinical Oncology; Clinical Trials; Collaborations; Communities; Community Clinical Oncology Program; Community Physician; Contracts; Education; Enrollment; Ensure; Family; Fostering; Foundations; Grant; Health; Health system; Healthcare Systems; Individual; Institutes; Investigation; Leadership; Mentors; Michigan; Minority; Mission; National Cancer Institute; National Clinical Trials Network; Newly Diagnosed; Oncologist; Patients; Persons; Population; Positioning Attribute; Preparation; Prevention; Recording of previous events; Research; Research Personnel; Resource Development; Role; Rural; Rural Hospitals; Saints; Site; Structure; Target Populations; anticancer research; base; cancer care; cancer clinical trial; care delivery; clinical care; control trial; evidence base; experience; health care disparity; medical schools; member; oncology; oncology program; programs; public health relevance; treatment trial; underserved minority

DESCRIPTION (provided by applicant): The Cancer Research Consortium of West Michigan (CRCWM), formed by two experienced Clinical Community Oncology Programs (CCOPs), a NCI Community Cancer Centers Program, one medical school and a basic science institute is ideally positioned to fulfill the role of a NCORP. CRCWM has a committed group of eleven health systems, 90+ knowledgeable investigators and a well-established administrative structure. CRCWM is a large accrue to NCI clinical trials and is able to enroll minorities, underserved and rural individuals. As demonstrated in this application, CRCWM is experienced in Cancer Care Delivery Research (CCDR) and committed to further development of resources to make additional contributions to this NCI initiative. The specific aims of the CRCWM are: 1. To maximize the accrual of patients to cancer clinical trials sponsored by the National Cancer Institute. 2. To become strong contributors to Cancer Care Delivery Research (CCDR). 3. To address health care disparities by expanding accrual of underserved and minority populations through enhanced relationships with community partners. 4. To maximize the adoption of NCI scientific findings into clinical care through education and engagement of clinical partners and health systems. 5. To expand our network and health system partnerships (rural and urban, large and small) in order to bring NCI clinical trials and education to targeted populations. 6. T develop and mentor young investigators and expand our leadership roles in the emerging National Clinical Trials Network (NCTN) in order to optimize our contribution to the national scientific agenda.

描述（由申请人提供）：由两个经验丰富的临床社区肿瘤学计划（CCOPS），NCI社区癌症中心计划，一所医学院和一家基础科学研究所组成的西密歇根州癌症研究联盟（CRCWM）在理想情况下扮演NCORP的作用。 CRCWM拥有一个坚定的11个卫生系统，90多个知识渊博的研究人员和一个公认的行政结构。 CRCWM是NCI临床试验的大型累积，并且能够招募少数群体，服务不足和农村个体。正如本应用程序所证明的那样，CRCWM在癌症护理递送研究（CCDR）方面经验丰富，并致力于进一步开发资源，为该NCI倡议做出其他贡献。 CRCWM的具体目的是：1。最大程度地提高了国家癌症研究所赞助的癌症临床试验的患者应计。 2。成为癌症护理递送研究（CCDR）的有力贡献者。 3。通过与社区合作伙伴的关系增强的关系来扩大服务不足和少数族裔人口的应计来解决医疗保健差异。 4。通过临床伴侣和卫生系统的教育和参与，将NCI科学发现最大化用于临床护理。 5。为了扩大我们的网络和卫生系统伙伴关系（农村和城市，大小），以便将NCI临床试验和教育带到目标人群中。 6。t开发和指导年轻的研究人员，并扩大我们在新兴国家临床试验网络（NCTN）中的领导角色，以优化我们对国家科学议程的贡献。